Jeena Sikho Lifecare Limited — Important, 26-06-2025: Updates

Jeena Sikho Lifecare Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company has secured approval for a clinical trial of its diabetes tablet, Shuddhi Dr. Madhumeh. The 3-month open-label study involves 40 participants and aims to evaluate the tablet’s safety and efficacy. This progress enhances the company’s product validation and could strengthen its positioning in the diabetes healthcare segment. No financial impact details provided yet.